Bruno Vergès

13.8k citations
294 papers · 8.1k · 2 hit papers · h-index 48

Impact in

    • Diabetes, Cardiovascular Risks, and Lipoproteins
    • Diabetes Treatment and Management
    • Diabetes Management and Research
    • Diet, Metabolism, and Disease
    • Liver Disease Diagnosis and Treatment
    • Neuroendocrine Tumor Research Advances

Papers in

    • Diabetes, Cardiovascular Risks, and Lipoproteins 63
    • Diabetes Treatment and Management 37
    • Diabetes Management and Research 28
    • Diet, Metabolism, and Disease 15
    • Lipoproteins and Cardiovascular Health 32

Bruno Vergès

270 papers receiving 7.9k citations

Bruno Vergès's Hit Papers

Efficacy and safety of once-weekly semaglutide 1.0 mg vs once-daily liraglutide 1.2 mg as add-on to 1–3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10) 2019 · 296 citations
2960+3+7Years since publication100200300400500

Peers

Bruno Vergès
Comparison fields: 5 of 134
  • Endocrinology, Diabetes and Metabolism 3.2k
  • Epidemiology 1.8k
  • Hepatology 425
  • Surgery 1.5k
  • Cardiology and Cardiovascular Medicine 769
Replace Bong Soo with:
Bong Soo South Korea
Ferdinando Carlo Sasso Italy
Andreas L. Birkenfeld Germany
Byung‐Wan Lee South Korea
Marju Orho‐Melander Sweden
Κωνσταντίνος Τζιόμαλος Greece
Vasilios G. Athyros Greece
Michiaki Fukui Japan
Asterios Karagiannis Greece
Chul Woo Ahn South Korea
Bruno Vergès relative to Bong Soo South Korea Bong Soo's profile →
Citations per field
00.5×1.5×
Bong Soo · 1×
Citations per year

Countries citing papers authored by Bruno Vergès

Since Specialization
Citations

This map shows the geographic impact of Bruno Vergès's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruno Vergès with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruno Vergès more than expected).

Fields of papers citing papers by Bruno Vergès

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruno Vergès. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruno Vergès. The network helps show where Bruno Vergès may publish in the future.

Co-authors

The 25 scholars most cited alongside Bruno Vergès, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bruno Vergès Line = papers co-authored together Bruno Vergès links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 294 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Pathophysiology of diabetic dyslipidaemia: where are we?
Hit paper breakdown →
2015520
2 2002309
3
Efficacy and safety of once-weekly semaglutide 1.0 mg vs once-daily liraglutide 1.2 mg as add-on to 1–3 oral antidiabetic drugs in subjects with type 2 diabetes (SUSTAIN 10)
Hit paper breakdown →
2019296
4 2017239
5 2001213
6 2008145
7 2010138
8 2012134
9 2014126
10 2006117
11 2009113
12 2003112
13 200593
14 200492
15
Dyslipidaemia in diabetes mellitus. Review of the main lipoprotein abnormalities and their consequences on the development of atherogenesis.
199990
16 202087
17 200586
18 200685
19 200984
20 200980

About Bruno Vergès

Bruno Vergès is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Epidemiology, Molecular Biology and Cardiology and Cardiovascular Medicine, having authored 294 papers that have together received 8.1k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (63 papers), Diabetes Treatment and Management (37 papers), Lipoproteins and Cardiovascular Health (32 papers), Diabetes Management and Research (28 papers), Liver Disease Diagnosis and Treatment (22 papers), Metabolism, Diabetes, and Cancer (19 papers), Lipid metabolism and disorders (18 papers) and Diet, Metabolism, and Disease (15 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (3.2k citations), Epidemiology (1.8k citations), Hepatology (425 citations), Surgery (1.5k citations) and Cardiology and Cardiovascular Medicine (769 citations). Bruno Vergès has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include Laurence Duvillard, Jean‐Michel Petit, Philippe Gambert, Benjamin Bouillet, Patrick Hillon, Bertrand Cariou, E Florentin, S. Halimi, Laurent Lagrost and Alexia Rouland. Their work appears in journals such as Diabetes & Metabolism, The Journal of Clinical Endocrinology & Metabolism, Atherosclerosis, Diabetologia and Arteriosclerosis Thrombosis and Vascular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact